TeraImmune Revenue and Competitors
Estimated Revenue & Valuation
- TeraImmune's estimated annual revenue is currently $155k per year.
- TeraImmune's estimated revenue per employee is $155,000
Employee Data
- TeraImmune has 1 Employees.
- TeraImmune grew their employee count by -50% last year.
TeraImmune's People
| Name | Title | Email/Phone |
|---|
TeraImmune Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.3M | 2 | 0% | N/A | N/A |
#2 | $3.6M | 46 | -31% | $17.5M | N/A |
#3 | $3.6M | 46 | -34% | $10.5M | N/A |
#4 | $30.2M | 156 | 0% | $69.4M | N/A |
#5 | $11.8M | 76 | -15% | N/A | N/A |
#6 | $1.7M | 11 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $8.8M | 57 | 19% | N/A | N/A |
#9 | $0.2M | 1 | -86% | N/A | N/A |
#10 | $2M | 13 | 18% | N/A | N/A |
What Is TeraImmune?
Key technical assets of TeraImmune 1) Expansion of human regulatory T cells in vitro 2) Receptors targeting pathological immune cells (T cell/ B cell/ antigen presenting cell) Grant awards 1) SBIR phase 1 (NHLBI, NIH) in April 2018 - grant for small businesses, scientifically verified 2) PACT program (NHLBI, NIH) in November 2018 - service grant supporting overall process development of the cell manufacturing: establishment of standard operating procedure (SOP), QA/QC and regulatory service
keywords:N/A
N/A
Total Funding
1
Number of Employees
$155k
Revenue (est)
-50%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Gaithersburg
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.3M | 2 | 0% | N/A |
#2 | $0.3M | 2 | 0% | N/A |
#3 | $0.3M | 2 | -50% | N/A |
#4 | $0.2M | 3 | -25% | N/A |
#5 | $0.2M | 3 | 50% | N/A |